Managing Hepatitis C Treatment Costs

Manufacturer coupons for high-cost medications, such as those that treat hepatitis C, make a huge difference for patients. Today’s hepatitis C medications have the potential to cure the majority of infected people; however, they can come with a steep price tag for both patients and payers. In order to bring down excessively high cost shares…

Cost and Value

Where does the true value of cancer treatment lie? Oncology experts grapple with this important question, with one of the more recent people to chime in being Robert C. Young, M.D., of RCY Medicine in Philadelphia, in an essay in a recent issue of the New England Journal of Medicine. Dr. Young reviews several initiatives…

Coping With ‘Financial Toxicity’

Multiple myeloma, a type of cancer affecting the bone marrow, will be diagnosed in an estimated 27,000 Americans this year. Advances in research are expanding treatment options and improving outcomes in multiple myeloma patients, but these new medications often come with a higher price point. The expensive treatments for this disease have triggered alarming developments:…

When Price Stands in the Way

Medication non-adherence can be traced back to numerous causes. For some patients, the side effects of a given medication become too burdensome. Sometimes it is simple forgetfulness that keeps a patient from faithfully taking all prescribed treatment. And then there is the cost burden of treatment. Price barriers account for a significant slice of the…

Timely Treatment

When one analyzes the medical records of 1.6 American adults, it turns out there’s a lot to be learned there. Researchers with the Chronic Hepatitis Cohort Study (CHeCS) did just that starting back in 2006 and tracked the ongoing health of those with hepatitis for the next numerous years. As the CHeCS researchers uncovered connections…

World Hepatitis Day

One of the key messages of today July 28th, World Hepatitis Day, is simply this: hepatitis C is a preventable and treatable disease. The World Health Organization created World Hepatitis Day to raise awareness about the massive number of people already infected with one of several hepatitis viruses, including the hepatitis C, and how anyone…

Staying With the Patient

Medication adherence issues account for a significant portion of avoidable health care costs each year, through drug waste, treatment failure, and medical complications. Identifying ways to improve adherence ripples out positively throughout the health care system – benefiting the patient, payers, and all other key players. The pharmacy model at BioPlus Specialty Pharmacy focuses on…

Making Assumptions

Many physicians would likely be surprised to learn that their patients are not as faithful at taking important medications as they think. Medication adherence continues to be a drain on optimal treatment outcomes for serious diseases. HealthPrize Technologies, an industry-leading medication adherence and digital patient engagement company, recently surveyed physicians about adherence. The physicians surveyed…

Biosimilars: Close to the Real Thing

The issue of “biosimilar” medications has been under debate for years. Now, the U.S. Food and Drug Administration (FDA) is on the cusp of approving the first biosimilar. In case you don’t know, biosimilars are less expensive versions of already approved biological medications used for cancer, autoimmune, and other diseases. Biologic medications are typically large…

Treat Hepatitis C Promptly For Your Liver…And Your Heart

As if it’s not bad enough to have chronic hepatitis C infection, with the damage that brings to the liver, it seems that the hepatitis C virus (HCV) also brings other health risks. Naga Pothineni, M.D. from the Division of Cardiology at the University of Arkansas for Medical Science and fellow researchers looked into the…